Blog
- Crashworthiness in the 2020s
Oct 27, 2024
Published in The Legal Intelligencer Below is a summary of “Crashworthiness in the 2020s,” published in The Legal Intelligencer: Crashworthiness, the obligation for manufacturers to design vehicles that protect occupants during crashes, has evolved since the 1968 Larson v. General Motors case. This duty now extends to many vehicles, including airplanes, buses, trucks, and motorcycles, covering protection in frontal, side, rear-end, and rollover collisions. Vehicle safety features aim to mitigate injuries regardless of seatbelt use or crash...Read More - Depo-Provera: Most Recent In a Long Line of Litigation Against Unsafe Birth Control Products
Oct 14, 2024
Birth control has been a revolutionary development for women’s reproductive health and autonomy. However, some forms of birth control have also come with serious risks, leading to a wave of lawsuits against manufacturers over the years. From the notorious Dalkon Shield in the 1980s to the more recent Depo-Provera litigation (related to the product’s increased risk of causing brain and spinal cord tumors), the legal landscape surrounding birth control devices and drugs has been fraught...Read More - A Lifetime of Legal Battles Against Dangerous Products
Oct 10, 2024
Tracy Finken Magnotta, Anapol Weiss Women’s Health Ligitation Team I Have Spent My Career Holding Companies Accountable for Marketing Unsafe Products and Failing to Disclose the Serious Risks to Consumers However, time and again, we see these companies prioritizing profits over safety. Billion-dollar products are marketed without proper warnings and the result is often catastrophic. Over the past 25 years, I have been passionate about representing women and children for the life-changing injuries they have sustained and...Read More - Tumors May Be Among the Side Effects of Depo-Provera Use: How to File a Lawsuit
Oct 9, 2024
Depo-Provera (medroxyprogesterone acetate), a long-acting contraceptive injection, is used by millions of women worldwide. While exact numbers can vary by region and over time, as of recent estimates: Global use: Around 20 million women worldwide have used Depo-Provera. United States: Approximately 1.6 million women use Depo-Provera in the U.S. annually. This accounts for about 3% of women using contraception in the country. Depo-Provera Side Effects and Meningiomas Depo-Provera is especially popular due to its convenience (one injection every three...Read More - Pfizer and Depo-Provera: Another Example of a Company Failing to Warn Women About Risks in Products and Medicines
Oct 7, 2024
In recent years, there has been a growing awareness of how certain companies have failed to adequately warn female consumers about the risks associated with their products and medicines. From pharmaceuticals to cosmetics, several high-profile cases have highlighted the negligence of corporations in protecting women’s health. The most recent example is Pfizer’s failure to warn millions of users of Depo-Provera about the injection’s increased risk of causing brain and spinal cord tumors (meningiomas). When research revealed...Read More - Informed Consent and Depo-Provera: Are Women Being Properly Informed?
Oct 7, 2024
Women deserve the right to make choices about their health, but only through full and accurate warnings and drug information can any woman make the decision that’s right for her. Women who aren’t properly informed about the risks of their birth control medications could be taking on serious health risks without even knowing it. That, along with the severe harm that has been linked to birth control injections in the form of an increased risk...Read More - Depo-Provera Lawsuits: Pfizer Hid the Ugly Truth from Women
Oct 6, 2024
Kila Baldwin is one of the leaders of the Anapol Weiss Women's Health Litigation Team. Kila is currently investigating cases of women who used Depo-Provera and developed brain or spinal cord tumors (meningiomas). Lifestyle drugs are medications prescribed not to treat an illness, but rather to help in your lifestyle. Millions of women for decades have taken prescribed birth control medications to avoid getting pregnant. There are other non-drug alternatives, like condoms, but taking a...Read More - Could Tumors Caused by Depo-Provera Have Been Avoided by a Safer Version Owned by Pfizer?
Oct 5, 2024
Shayna Slater, Anapol Weiss Women’s Health Ligitation Team Depo-Provera, a popular hormonal contraceptive, has been a go-to choice for many seeking birth control. Administered via injection every three months, it purported to offer convenience and effectiveness. However, there is now evidence that it also increased women’s risk of brain and spinal tumors, called meningiomas. A Safer Alternative Sadly, initial research suggests that Pfizer actually owned a safer alternative. While investigation continues, if Pfizer did, in fact, own a...Read More - Health Implications: How the Depo-Provera Lawsuit Highlights Women's Health Concerns
Oct 4, 2024
The birth control shot, a contraceptive delivered by injection every 12 weeks, has been hailed as a convenient alternative for women who don’t want to take birth control pills daily. Unfortunately, recent research findings have raised serious concerns about the safety of this medication. The recent Depo-Provera lawsuits are the latest mass tort legislation arising out of women’s health concerns. For patients who did or currently do use Depo-Provera for birth control, it’s important to understand...Read More - Depo-Provera Lawsuits: Yet Another Example of Women Fighting Back Against Harmful Drugs
Oct 4, 2024
By: Anapol Weiss Women’s Health Litigation Team Depo-Provera, the popular injectable contraceptive containing medroxyprogesterone acetate, has been marketed as a safe, convenient, long-term birth control solution. However, recent research has linked it to an increased risk of brain and spinal cord tumors (“meningiomas”). Depo-Provera: The Legal Fallout The first lawsuit against the drug’s manufacturer, Pfizer, was filed on October 1, 2024, accusing the pharmaceutical giant of failing to disclose the risks associated with long-term use of the drug...Read More